234 related articles for article (PubMed ID: 36653940)
1. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
[TBL] [Abstract][Full Text] [Related]
2. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges.
Kim HO
Arch Pharm Res; 2022 Dec; 45(12):894-908. PubMed ID: 36462097
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of biologics in atopic dermatitis.
Wu J; Guttman-Yassky E
Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
[No Abstract] [Full Text] [Related]
4. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
Munera-Campos M; Carrascosa JM
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging biologic and small molecule therapies for atopic dermatitis.
Li R; Hadi S; Guttman-Yassky E
Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
[TBL] [Abstract][Full Text] [Related]
6. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
8. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
[TBL] [Abstract][Full Text] [Related]
9. Diversity of atopic dermatitis and selection of immune targets.
Rothenberg-Lausell C; Bar J; Del Duca E; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2024 Feb; 132(2):177-186. PubMed ID: 38008215
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Guttman-Yassky E; Krueger JG
Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
[TBL] [Abstract][Full Text] [Related]
11. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
12. New era of biologic therapeutics in atopic dermatitis.
Guttman-Yassky E; Dhingra N; Leung DY
Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
[TBL] [Abstract][Full Text] [Related]
13. [Emerging systemic treatments of atopic dermatitis].
Di Lucca-Chrisment J; Gilliet M
Rev Med Suisse; 2018 Mar; 14(600):685-689. PubMed ID: 29589655
[TBL] [Abstract][Full Text] [Related]
14. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
[TBL] [Abstract][Full Text] [Related]
16. Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials.
Yang X; Kambe N; Takimoto-Ito R; Kabashima K
Pharmacol Ther; 2021 Aug; 224():107830. PubMed ID: 33662453
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis endotypes: knowledge for personalized medicine.
Kim J; Ahn K
Curr Opin Allergy Clin Immunol; 2022 Jun; 22(3):153-159. PubMed ID: 35152229
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Atopic Dermatitis and Psoriasis Vulgaris: Implications for Targeted Biologic Therapy.
Johnson MC; Bowers NL; Strowd LC
Cutis; 2022 Feb; 109(2):110-112. PubMed ID: 35659797
[TBL] [Abstract][Full Text] [Related]
19. Atopic dermatitis in skin of colour. Part 1: new discoveries in epidemiology and pathogenesis.
Gan C; Mahil S; Pink A; Rodrigues M
Clin Exp Dermatol; 2023 Jun; 48(6):609-616. PubMed ID: 37002798
[TBL] [Abstract][Full Text] [Related]
20. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
Brunner PM; Guttman-Yassky E; Leung DY
J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
